Voluntary nationwide recall: Clonazepam (Endo – November)

Dec. 2024Pharmacy Updates

Endo USA Inc. has recalled certain lots of Clonazepam Orally Disintegrating Tablets, USP (C-IV). This is an expansion of a previous recall by Endo. Clonazepam is used to treat panic disorder and certain seizures.

This product is being recalled because the cartons of some packs show the incorrect product strength. The blister strips inside the product pack show the correct strength.

Using this drug at a higher dose than prescribed may cause sleepiness, dizziness, loss of muscle control, and confusion.

To see if your medication was recalled, please contact your doctor or the pharmacy where you received it or visit the FDA website below. If you have an affected lot of Clonazepam, you should stop using the medicine and return it to the place where you got it or throw it away.

As of Nov. 18, there had been no reports of adverse events related to this recall.

To learn more about this recall:

  • Call Inmar Inc. at 1-855-589-1869. Help is available Monday through Friday from 9 a.m. to 5 p.m. EST.
  • Visit the FDA website.

Recent Announcements

PA DOH Antibiotic Stewardship Resources

Order antibiotic stewardship resources at no cost
Jun. 2026Important Notices

Medical device correction: Omnipod (Insulet – May 2026)

Insulet Corporation Inc. has announced a medical device correction for certain Omnipod Pods. These pods are wearable devices that are used to deliver insulin.
Jun. 2026Pharmacy Updates

Clinical documentation required for medical policy prior authorizations

As you know, UPMC Health Plan requires certain clinical documentation/notes in support of a request for prior authorization for the listed procedures below in accordance with its established policies and procedures, in addition to CMS requirements that medical record documentation must support the medical necessity of the services requested.
Jun. 2026Important Notices